News
Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new ...
Kraft Heinz said it will remove artificial dyes from its U.S. products by end of 2027 and stop making new products that ...
The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with ...
The program will bring together experts from across the FDA for a team-based review, rather than having an application move ...
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...
A Mexican national who federal prosecutors say illegally reentered the United States three times was sentenced to nearly a ...
Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He’s long wanted to ...
The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. | The FDA is introducing a ...
The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...
The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...
Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results